Jazz Pharmaceuticals
JAZZ
#2067
Rank
$7.46 B
Marketcap
$122.92
Share price
-2.75%
Change (1 day)
3.31%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): $0.47 Billion USD

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are $4.06 Billion USD. , an increase over its 2023 earnings that were of $0.29 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 $0.47 B57.87%
2023 $0.29 B-179.92%
2022 -$0.38 Billion230.37%
2021 -$0.12 Billion-141.02%
2020 $0.27 B-39.45%
2019 $0.45 B-14.2%
2018 $0.52 B20.03%
2017 $0.44 B-17.15%
2016 $0.53 B22.14%
2015 $0.43 B187.64%
2014 $0.15 B-50.79%
2013 $0.30 B73.63%
2012 $0.17 B41.69%
2011 $0.12 B116.61%
2010 $57.78 M262.77%
2009 $15.93 M-111.33%
2008 -$0.15 Billion1.31%
2007 -$0.14 Billion77.8%
2006 -$78.06 Million36.59%
2005 -$57.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$2.4 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$2.09 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.64 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$0.29 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel